Further studies also suggest that the class IIb HDAC sub-family member, HDAC10 may exert specific roles in neuroblastoma progression, as elevated HDAC10 expression has previously been associated with poor clinical outcomes in high risk neuroblastoma patients (Oehme et al., 2013). The gene discussed is HDAC9; the disease is neuroblastoma.